纳斯达克： -- -- --

最近浏览

实时行情

意见反馈

礼来制药

NYSE:LLY 延时15分钟
  • 今开：--
    昨收：--
  • 今日区间：--
    52周区间：--
  • 成交量：--
    成交额：--
  • 市 值：--
    市盈率：--
  • 振幅：
    每股收益：
成交量

董事会

David A. Ricks
David A. Ricks is currently Chairman, President & Chief Executive Officer at Eli Lilly & Co. since 2017. He is also Chairman & Chief Executive Officer at Eli Lilly & Co. Ltd. and Eli Lilly Italia SpA. He serves as Chairman-Governors Board at James Whitcomb Riley Children's Foundation. Since 2018, he has been an Independent Director at Adobe, Inc. He is a Director at Pharmaceutical Research & Manufacturers of America since 2022 and at The Central Indiana Corporate Partnership. He is a Member of The Business Roundtable and The Business Council. Former positions include Director at European Federation of Pharmaceutical Industries & Assns, Director at Elanco Animal Health, Inc. from 2018 to 2019, Principal at HP, Inc., Principal at International Business Machines Corp., President at International Federation of Pharmaceutical Manufacturers, President at Lilly USA LLC from 2009 to 2012, President & General Manager at Lilly Industries Shanghai Ltd. in 2009, and General Manager at Eli Lilly Canada, Inc. from 2005 to 2008. Education includes an MBA from Indiana University in 1996 and an undergraduate degree from Purdue University in 1990.
Jon Erik Fyrwald
Jon Erik Fyrwald is Chief Executive Officer & Director at International Flavors & Fragrances, Inc. since 2024. Holds CEO roles at Syngenta Crop Protection . Solu es Para A Agricultura, Ltda., Syngenta Foundation For Sustainable Agriculture (Chairman & CEO), Syngenta Bangladesh Ltd. (CEO & Director), and Syngenta International AG (CEO & Director since 2016). Chairman of ADAMA Ltd. since 2020. Independent Director at Eli Lilly & Co. since 2005. Director at Biotechnology Innovation Organization, Syngenta AG, ADAMA Agricultural Solutions Ltd. (since 2022), Society of Chemical Industry, The Chicago Public Education Fund, CropLife International, Syngenta Crop Protection AG (since 2023), Syngenta Group Co., Ltd. (since 2023), and Trustee at The Field Museum of Natural History since 2010. Former roles include Chairman, President & CEO at Nalco Co. and Nalco Holding Co. (2008 2011), President & CEO at Univar NV, Univar Solutions UK Ltd., Univar Solutions USA, Inc. (Illinois), and Univar Solutions, Inc. (2012 2016). Chairman at Sinofert Holdings Ltd. (2020 2023). Chairman-Management & Member-Management Director at Syngenta AG. Independent Director at Bunge Ltd. (2018 2023). Group VP-Agriculture & Nutrition Division at EIDP, Inc. (2003 2008). President at Ecolab, Inc. (2011 2012). Director roles at Amsted Industries, Inc., 8th Continent LLC, American Chemistry Council, Inc., Edmundson Art Foundation, Inc., United Way of Central Iowa, World Food Programme, and Swiss-American Chamber of Commerce. Education includes an undergraduate degree from the University of Delaware, conferred in 1981.
Ralph Alvarez
Ralph Alvarez is Independent Chairman at First Watch Restaurant Group, Inc. since 2019. Independent Director at Eli Lilly & Co. since 2009. Independent Director at Lowe's Companies, Inc. since 2010. Lead Independent Director at Traeger, Inc. since 2021. Member-Presidents Council at the University of Miami School of Business. Former Executive Chairman at Skylark Co. Ltd. from 2013 to 2018. Former Chairman at Skylark Holdings Co., Ltd. from 2013 to 2018. Former Director at KeyCorp from 2005 to 2009. Former President, Chief Operating Officer & Director at McDonald's Corp. from 2006 to 2009. Former Regional Director at Chipotle Mexican Grill, Inc. from 1999 to 2000. Former Lead Independent Director at Dunkin' Brands Group, Inc. from 2012 to 2020. Former Director at Dunkin' Brands, Inc. from 2013 to 2020. Former Independent Director at Anywhere Real Estate, Inc. from 2013 to 2018. Former Vice President-Florida Division at Wendy's International LLC from 1990 to 1994. Former Budget Analyst at Burger King Corp. from 1977 to 1989. Former President at McDonald s North America from 2005 to 2006. Former President at McDonald's Mexico in 2005. Former COO & President-Central Division at McDonald's USA LLC from 2006 to 2009. Education includes an undergraduate degree from the University of Miami, conferred in 1976.
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
Katherine Baicker
Katherine Baicker is currently an Independent Director at Eli Lilly & Co., a Trustee at Mayo Clinic, a Member of the Council on Foreign Relations, American Academy of Arts & Sciences, National Academy of Medicine, National Bureau of Economic Research, The Chicago Council on Global Affairs, National Opinion Research Center, and National Academy of Social Insurance. She is also the Dean & Professor at The University of Chicago Harris School of Public Policy and the Dean at Harris School of Public Policy Studies. Her former jobs include Chairman-Social Sciences & Population Study at National Institutes of Health, Vice Chairman at AcademyHealth, Chairman at The Group Insurance Commission, Independent Director at HMS Holdings Corp., Associate Professor & Assistant Professor at Dartmouth College, Member of Council of Economic Advisers, and Professor-Health Economics at Harvard T.H. Chan School of Public Health. She is also a former Trustee at The Urban Institute and a Member-Editorial Board at Health Affairs. Baicker received her doctorate from Harvard University and her undergraduate degree from Yale University.
David A. Ricks
David A. Ricks is currently Chairman, President & Chief Executive Officer at Eli Lilly & Co. since 2017. He is also Chairman & Chief Executive Officer at Eli Lilly & Co. Ltd. and Eli Lilly Italia SpA. He serves as Chairman-Governors Board at James Whitcomb Riley Children's Foundation. Since 2018, he has been an Independent Director at Adobe, Inc. He is a Director at Pharmaceutical Research & Manufacturers of America since 2022 and at The Central Indiana Corporate Partnership. He is a Member of The Business Roundtable and The Business Council. Former positions include Director at European Federation of Pharmaceutical Industries & Assns, Director at Elanco Animal Health, Inc. from 2018 to 2019, Principal at HP, Inc., Principal at International Business Machines Corp., President at International Federation of Pharmaceutical Manufacturers, President at Lilly USA LLC from 2009 to 2012, President & General Manager at Lilly Industries Shanghai Ltd. in 2009, and General Manager at Eli Lilly Canada, Inc. from 2005 to 2008. Education includes an MBA from Indiana University in 1996 and an undergraduate degree from Purdue University in 1990.
William G. Kaelin
William G. Kaelin is the founder of Tango Therapeutics Sub, Inc. (founded in 2017), Cedilla Therapeutics, Inc. (founded in 2017), and Tango Therapeutics, Inc. (founded in 2017). Current jobs include Independent Director at Eli Lilly & Co. since 2012, Director at The Damon Runyon Cancer Research Foundation, Director at LifeMine Therapeutics, Inc. since 2021, Director at IconOVir Bio, Inc. since 2022, Independent Director at IQVIA Holdings, Inc. starting 2025, Trustee at Duke University, Professor at Dana-Farber Cancer Institute, Inc., Professor at The Brigham & Women's Hospital, Inc. since 2002, Member of the National Academy of Sciences, Member of the American Academy of Arts & Sciences, Member of the Association of American Physicians, Member of Dana-Farber, Member of the American Society of Clinical Investigation, Professor at Harvard Medical School since 2002, and Advisor at Casdin Capital. Former jobs include Chief Resident & House Officer at The Johns Hopkins Hospital, Inc., Member-Advisory Board at National Cancer Institute, Member of the National Academy of Medicine (United States), Member of the American College of Physicians, Inc., and Trustee of the American Association for Cancer Research. Education includes undergraduate degree from Duke University in 1982 and a doctorate from Duke University School of Medicine.
Juan Ricardo Luciano
Juan Ricardo Luciano is currently the Chairman, President & Chief Executive Officer at Archer-Daniels-Midland Co. He is also the Lead Independent Director at Eli Lilly & Co. Additionally, he holds director positions at Rush System for Health, The Business Council, ADM Grain River System, Inc., ADM Clinton BioProcessing, Inc., Intersect Illinois, The Commercial Club of Chicago, The Business Roundtable, Dow Hydrocarbons & Resources LLC, Global Advisory Board, and The Economic Club of Chicago. In the past, Mr. Luciano served as a Director at ADM Alliance Nutrition, Inc. and as a Non-Executive Director at Wilmar International Ltd. He also held director positions at The Economic Club of Chicago (Illinois), Kellogg School of Management, and The Dow Chemical Co., where he was the President-Performance Division. Furthermore, he served as a Trustee at Boys & Girls Clubs of America and Rush University Medical Center, and as a Member of the US-China Business Council. Mr. Luciano completed his undergraduate degree at Instituto Tecnol gico de Buenos Aires.
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
Jamere Jackson
Jamere Jackson is currently an Independent Director at Eli Lilly & Co. since 2016, a Director at Azaa Investments, Inc., Youth Villages, Inc., and Future 5, and the Chief Financial Officer at AutoZone, Inc. since 2023. Former roles include Independent Director at Hibbett, Inc. from 2020 to 2022; Chief Financial Officer & Executive Vice President at The Hertz Corp. and Hertz Global Holdings, Inc. from 2018 to 2020; Chief Financial Officer at Nielsen Holdings Ltd. from 2014 to 2018; VP, Chief Financial Officer-Drilling & Surface at Baker Hughes Energy Services LLC from 2013 to 2014; Senior Executive-Finance at GE Aviation Systems LLC from 2007 to 2013; Principal at GE Aerospace from 2004 to 2014; and Principal at First Data Corp., Procter & Gamble Co., Total System Services LLC, Yum!. Brands, Inc., The Nielsen Company (US) LLC, Nielsen NV, and VNU NV. Treasurer at Unison Industries LLC. Education includes an undergraduate degree from the University of Notre Dame, conferred in 1990.
Gabrielle G. Greene-Sulzberger
Ms. Gabrielle G. Greene-Sulzberger is an Independent Director at Eli Lilly & Co., a Senior Advisor at Centerbridge Partners LP, a Chairman at The Food Kitchen Ltd., a Chairman at True Food Kitchen Investco LLC, an Independent Director at Mastercard, Inc., an advisor at Two Sigma Impact, a Chairman at auxmoney GmbH, a Chairman at Sesame Workshop, a Director & Member at Trinity Church Wall Street, a Member at Henry Crown Fellowship Program and a Member at Massachusetts Bar Association. She is on the Board of Directors at Eli Lilly & Co., The LiveKindly Co., Inc., Cerevel Therapeutics LLC, Mastercard, Inc., Acorns Grow, Inc., Cerevel Therapeutics, Inc., Sesame Street, The Metropolitan Museum of Art, Time's Up, Timesup Ltd., Womencorporatedirectors Foundation and Trinity Church Wall Street. Ms. Greene-Sulzberger was previously employed as an Independent Director by Warby Parker, Inc., a Trustee by The Conference Board, Inc., an Independent Director by Cerevel Therapeutics Holdings, Inc., an Independent Director by Brixmor Property Group, Inc., a Chief Executive Officer by Johnson Products Co., Inc., an Independent Director by Stage Stores, Inc., a General Partner by Fontis Partners LP, an Independent Director by Whole Foods Market, Inc., a Chief Financial Officer by Villanueva Cos., a Chief Financial Officer by Crown Services, Inc., a Chief Financial Officer by Gluecode Software, Inc., a Principal by Commonwealth Enterprises, Inc., a General Partner by Rustic Canyon/Fontis Management LLC, a Chairman-ESG Practice by Teneo Consulting LLC, and a Chairman-ESG Practice by Teneo Holdings LLC. She also served on the board at IndyMac Bank FSB, CIT Bank NA, Bright Horizons Solutions Corp., Acorn Advisors LLC, Bright Horizons, Inc., Justworks, Inc. and Teva Pharmaceutical Industries Ltd. She received her undergraduate degree from Woodrow Wilson School of Public & International Affairs, a graduate degree from Harvard Law School and an MBA from Harvard Business School.
Kimberly H. Johnson
Kimberly H. Johnson is currently an Independent Director at Eli Lilly & Co. since 2021. Kimberly is also a Director at Greater Washington Board of Trade, Share Our Strength, Inc., Calvert Impact Capital, Inc., After-School All-Stars, Planet Works, Inc., and Communities In Schools of The Nations Capital. Kimberly serves as a Trustee at Princeton University. Former roles include Director at Credit Suisse Group AG and Credit Suisse (USA) LLC. Kimberly was Chief Operating Officer & Executive Vice President at Federal National Mortgage Association from 2018 to 2022. Kimberly worked as an Equity Trader at D. E. Shaw & Co. LLC. Kimberly was Chief Operating Officer at T. Rowe Price Group, Inc. from 2022 to 2025. Kimberly completed undergraduate studies at Princeton University and earned an MBA from Columbia Business School.
Mary Lynne Hedley
Mary Lynne Hedley founded Zycos, Inc. in 1996, where she worked as President & Chief Executive Officer from 1996 to 2004 and Tesaro, Inc. in 2010, where she is working as President & Director. Dr. Hedley also currently works at Eli Lilly & Co., as Independent Director from 2022, Veeva Systems, Inc., as Independent Director from 2019, Millendo Therapeutics US, Inc., as Director from 2017, Helsinn Holding SA, as Director from 2021, Youville Place, as Director, Centessa Pharmaceuticals Plc, as Independent Non-Executive Director from 2021, Women Innovating Together In Healthcare, as Director, Youville Assisted Living Residences, as Director, Third Rock Ventures LLC, as Venture Partner from 2023, The American Association of Immunologists, as Member, American Association for the Advancement of Science, as Member, American Society of Clinical Oncology, Inc., as Member, and The American Association of Cancer Research, as Member. Dr. Hedley also formerly worked at Receptos LLC, as Independent Director from 2014 to 2015, bluebird bio, Inc., as Independent Director from 2017 to 2019, Millendo Therapeutics, Inc., as Independent Director from 2017 to 2021, Helsinn Healthcare SA, as Director from 2021 to 2023, MGI PHARMA, Inc., as Chief Scientific Officer & Executive VP from 2004 to 2008, Abraxis BioScience, Inc., as Chief Scientific Officer & EVP-Operations from 2009 to 2010, Eisai Corp. of North America, as Executive Vice President from 2008 to 2009, and MGI PHARMA Biologics, Inc., as General Manager & Senior Vice President. Dr. Hedley received her undergraduate degree in 1983 from Purdue University and doctorate degree in 1988 from The University of Texas Southwestern Medical Center.
Jon R. Moeller
Jon R. Moeller is Chairman, President & Chief Executive Officer at Procter & Gamble Service GmbH. He is Executive Chairman at Procter & Gamble Co. starting in 2026. He serves as Chief Operating Officer, CFO & Vice Chairman at Procter & Gamble (Manufacturing) Ireland Ltd. He is Director at MDVIP LLC (Florida), Natura Pet Products, Inc., The Consumer Goods Forum, Isle of Harris Distillers Ltd., Alliance To End Plastic Waste, The Business Roundtable, and Eli Lilly & Co. since 2024. He is Trustee at Commercial Club of Cincinnati, Vice President at Cincinnati Art Museum, and Member of The Conference Board Council of Financial Executives. Former roles include Independent Director at Monsanto Co. from 2011 to 2018 and Trustee at Visiting Nurse Association. Education includes an undergraduate degree (1986) and an MBA (1988) from Cornell University.
Carolyn R. Bertozzi
Carolyn R. Bertozzi is the founder of Redwood Bioscience, Inc. (founded in 2008), Palleon Pharmaceuticals, Inc. (founded in 2015), Venn Biosciences Corp. (founded in 2017), Lycia Therapeutics, Inc. (founded in 2019), and TwoStep Therapeutics, Inc. (founded in 2024). Dr. Bertozzi is also the founder of Firefly Bio, Inc.,Enable Biosciences, Inc... Dr. Bertozzi is currently Director at Grace Science Foundation, Independent Director at OmniAb Operations, Inc., Independent Director at OmniAb, Inc. since 2022, Director at Stanford Chem-H since 2021, Director at Xaira Therapeutics, Inc., Director at Eli Lilly & Co. starting 2025, Professor at Stanford University, Member of the American Chemical Society, Member of The Royal Society, Professor at Howard Hughes Medical Institute, Inc., Member of the National Academy of Sciences, Member of the American Academy of Arts & Sciences, Member of the National Academy of Medicine (United States), Member of the American Society for Biochemistry & Molecular Biology, Inc., Member of Accademia Nazionale dei Lincei, and Member of the National Academy of Inventors. Former positions include Independent Director at Eli Lilly & Co. from 2017 to 2021, Director-Molecular Foundry at Lawrence Berkeley National Laboratory, Director at The Broad Institute, Inc., Director at Catalent, Inc., Director at Molecular Foundry, Independent Director at Alnylam Pharmaceuticals, Inc. from 2023 to 2025, and Professor at the University of California, Berkeley from 1996 to 2015. Education includes an undergraduate degree from Harvard University conferred in 1988 and a doctorate from the University of California, Berkeley conferred in 1993.